- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Optical imaging firm submits application
Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser
Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser Mammography (CTLM), is designed as an adjunct to x-ray mammography for women who have dense breasts and equivocal mammograms, adding information to guide biopsy recommendations. Clinical studies of the technology began six years ago (SCAN 2/19/97).
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
